"10.1371_journal.pone.0017189","plos one","2011-04-15T00:00:00Z","Ferenc A Scheeren; Caroline M M van Geelen; Etsuko Yasuda; Hergen Spits; Tim Beaumont","Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; AIMM Therapeutics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Tytgat Institute, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands","Conceived and designed the experiments: FAS HS TB. Performed the experiments: FAS CMMvG EY TB. Analyzed the data: FAS CMMvG EY HS TB. Wrote the paper: FAS CMMvG HS TB.","F.A.S., E.Y., H.S. and T.B. are listed on patent applications (international patent PCT/NL2008/050333 entitled RSV specific binding molecules and means for producing them and PCT/NL2005/000848 Means and methods for influencing the stability of cells (to the patent offices of Japan, the U. S., Brazil, Canada, Europe, Australia and New Zealand). E.Y., H.S. and T.B. are employees of AIMM Therapeutics. H.S. has personal financial interests in AIMM Therapeutics. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","04","Ferenc A Scheeren","FAS",5,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
